Introduction
AIDS is caused by the human immunodeficiency virus (H/V) (Barr6- Sinoussi et al., 1983; Gallo et al., 1984) . Serum antibodies against the major core protein, p24, of HIV-1 appear early in infection together with antibodies against envelope proteins as serological markers (JollerJemelka et al., 1987) . Disease progression is to some extent associated with higher extracellular core antigen levels and a decline in the level of antibodies against p24 in serum Lange et al., 1986) . As the amino acid sequence of p24 is highly conserved, this protein has been used to develop screening assays to measure the serum antibodies to p24 for diagnostic and prognostic reasons Mathiesen et al., 1989) .
More and more synthetic peptides are being used to map antibody-binding sites of proteins used in diagnostic assays. Immunoassays which are based on synthetic peptides are in principle superior to assays based on whole protein, because such assays are less costly and, in theory, more specific than assays using whole protein. In this report immunoreactive peptides of p24 were selected with the aid of the Pepscan method (Geysen et al., 1984) . With this method overlapping nonapeptides covering the complete amino acid sequence of p24 of HIV-1 were tested for their reactivity with polyclonal antibodies and monoclonal antibodies raised against viral lysate, as well as with patients' sera. The detected antibody-binding sites were superimposed on a structural model of p24, recently proposed by Argos (1989) . This model is based upon the homology between p24 of HIV and the coat protein VP2 of the picornaviruses (Argos, 1989) . The results show that the antibody-binding sites are located largely on loops, turns and coils of p24. Only peptide sequences that correspond with the N-and C-terminal part of the 'puff' region bind antibodies.
Methods
Pepscan. Overlapping peptides of p24 of HIV-1 (strain HTLV-IIIB) were synthesized and tested for reactivity patterns of antisera and MAbs as described before (Geysen et al., 1984 (Geysen et al., , 1985 . In short, scanning for antibody-reactive peptides required the synthesis of every overlapping peptide of the relevant protein sequence. For example, in the case of a nonapeptide scan, a protein of n residues can be read as (n-8) overlapping nonapeptides, in which peptide 1 consists of residues 1 to 9, peptide 2 of residues 2 to 10 and so on. The amino acid sequence was derived from the nucleotide sequence of HTLV-IIIB (Ratner et al., 1985) . The peptides, still coupled to the solid supports, were then tested against the appropriate antibodies in a normal ELISA. Absorbance values were plotted against the position of the N-terminal amino acid of the peptide in the total sequence. If more than one peptide of a set of overlapping peptides reacted, the peptide that reacted best was considered to be the core of the antibody-binding site. When a set of overlapping peptides reacted equally, the shared amino acids in the reactive peptides were considered to constitute the antibody-binding site.
Preparation of MAbs.
Anti p-24 MAbs were obtained by immunization with purified HIV-1/H9 (strain IIIB) viral lysate as described previously (Tersmette et al., 1989) . Primary screening was performed using viral lysate-coated wells. The specific binding of MAbs OT37A, OT38B and OT39A to p24 was confirmed by immunoblotting (data not 0000-9629 © 1990 SGM
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shown) and the specificity of MAbs CLB-21, CLB-59 and CLB-19.7 was confirmed by immunoblotting and a radioimmunoprecipitation assay (Tersmette et al., 1989) .
Preparation of antisera. Rabbit anti-HIV sera were obtained by repeated immunization with 200 ~tg Triton X-100-disrupted purified HIV proteins (Tersmette et al., 1989) . Sheep anti-HIV sera were obtained by the same procedure.
Human sera. Sera were obtained from six patients with AIDS (numbers 1 to 6) and six asymptomatic, HIV-l-infected individuals (numbers 7 to 12). All sera were positive for HIV-I.
Results
MAbs and polyclonal antibodies were applied in Pepscan analyses to determine the antigenic sites on the major core protein p24 of HIV-1. Representative results for all overlapping nonapeptides are shown in Fig. 1 . The Pepscan data obtained with anti-p24 MAbs, rabbit antisera raised with viral lysate, sheep antisera raised with viral lysate and sera of humans infected with HIV-1 are summarized in Fig. 2 . The antibody-binding sites of the MAbs and the antiserum of rabbit 2 indicated in Fig.  2 are superimposed on the proposed structure of p24 of HIV-1 (Argos, 1989) as shown in Fig. 3 . Six different antibody-binding sites are detected using MAbs (Fig.2a , Table 1 ). Those sites which are part of the model are located on turns between the a-helix and strand D, strands D and E, and strands H and I. A majority of the MAbs reacted with amino acid sequences between amino acids 83 and 99 between the a-helix and strand D; this antibody-binding site appears to be immunodominant in mice. MAb CLB-19.7 and MAb CLB-MG reacted also with peptide 1 (Fig. lb; Fig. 2a ). Although we cannot exclude the possibility that both peptides reacted with the MAbs because they are part of a single discontinuous epitope, a more likely explanation is that both peptides react due to their sequence homology; the amino acid sequence of reactive peptide 1 is PIVQNIQGQ whereas the shared amino acids of the reactive peptides 89 and 90 are PIAPGQMR. This partial sequence homology may account for the crossreactivity of the MAbs.
The rabbit antisera reacted with the turns between strands B and C, strands D and E, strands H and I and ahelix and strand D, the N-terminal part of the a-helix, Cterminal part of the puff, strand E and the N-terminal part of strand D ( Fig. 2b; Fig. 3b ).
The sheep antisera reacted with turns between strands B and C, a-helix and strand D, strands D and E, strands G and H, the C-terminal part of strand B, a-helix, Cterminal part of the puff and a major part of strands D and E (Fig. 2b) . The human sera reacted with the turns between strands B and C, a-helix and strand D, strands D and E, strands F and G, the C-terminal part of the puff, the centre of the a-helix and strand D (Fig. 2c) . The reactivity o~" the polyclonal antibodies is broader than the reactivities of the MAbs taken together; the polyclonal antibodies reacted not only with amino acid sequences on the exposed loops but also with amino acid sequences that seem inaccessible in the model, i.e. strands E or D (Fig. 3) .
As the best possible alignment of HIV p24 and picornaviral VP2 is achieved by introducing some deletions and insertions, some parts of the proposed model may differ from the unknown three-dimensional structure of p24. 
.m, Summarized are the reactive sequences with an absorbance reading threefold higher than the background and which occurred in three or more of the 12 human sera. On the bottom line, the secondary structures of p24 of H IV-1 proposed by Argos (1989) are shown. The flstrands are marked B to I according to the nomenclature of Rossmann et al. (1985) for the rhinoviral coat protein fold. In (c) above the p24 sequence, the position of//-strands B to I are represented by a bar ( ); the or-helix is represented by an open box (r-"l).
Secondary structure predictions were made using the Garnier algorithms (Garnier et al., 1978) for those parts which correspond with two major 'insertions' in the primary sequence of p24 when compared to the primary sequence of VP2 (Argos, 1989). The secondary structure predictions for the puff region and the region between strands C and D are shown in Fig. 4 . Unlike the ribbon drawing of Fig. 3 , the puff region has a low turn and coil propensity (Fig. 4a) and high sheet propensity. Except for the C-terminal part, the region is quite hydrophobic, Fig. 3 . The antigenic sites superimposed on the predicted fold of the retroviral p24 core protein as proposed by Argos (1989) : (a) peptides that react with MAbs; (b) peptides that react with polyclonal sera raised in rabbit 2. The fl-strands are marked B to I according to the nomenclature of Rossmann et al. (1985) for the rhinoviral coat protein fold. 'Exterior' and 'interior' refer to the supposed orientation of p24 in the intact core particle. (Garnier et al., 1978) for the puff region (a) and the region between strands C and D (b). The numbers between parentheses represent the position of the N-terminal amino acid of parts of p24 shown (Rather et al., 1985) . Amino acids are presented in the singl eletter code (in this figure, lower case). A dash (--) represents 'extended'; asterisk (*) represents 'coil'; H, ~-helix; T, turn. (Argos, 1989) . The loop between strands G and H is shortened, the puff region is altered and a loop is inserted between the extended helix and strand D. which also suggests a low surface propensity (Hopp & Woods, 1981) . High turn and coil propensity is predicted for a region C-terminal to the s-helix (Fig. 4b) . This region corresponds to an immunodominant antigenic site that reacts frequently with the polyclonal sera and the MAbs (Fig. 2) .
Discussion
With the aid of the alignment of Argos (1989, Fig. 5 ) together with the secondary structure predictions (Fig.  4b) , we propose a slightly modified model for p24 of HIV-I: between the c~-helix and strand D we have inserted a loop (Fig. 3) . It has been shown for other proteins that, in general, antibody-binding sites are located on loops and turns but hardly ever on B-strands (Garnier et al., 1978; Chou & Fasman, 1979; Fanning et al., 1986; Getzoff et al., 1986; Novotny et al., 1986) .
In this study we demonstrated that linear antibodybinding sites were mapped to every turn and loop of the B-barrel and to the e-helix of the proposed p24 model (Fig. 3 ) which is compatible with the proposed structure: the superimposition of all sites on the model is summarized in Fig. 5 . The insertion between the e-helix and strand D is immunodominant and is probably well exposed, because many MAbs and polyclonal antibodies map to this site ( Fig. 1 to 3) . A few binding sites are mapped to amino acid sequences of non-protruding Bstrands. For instance there are several patients' sera that react with amino acid sequences of strand D. Furthermore, rabbit and sheep sera reacted with amino acid sequences of strands D and E. The polyclonal sera contain antibodies to turns, loops and B-sheets. The ratio of antibodies to turns and loops compared to B-sheets is higher than the occurrence of turns and loops compared to B-sheets in p24. Antibodies in the polyclonal sera against less exposed sites may be induced by processing of the protein by the immune system.
It was shown before (Tersmette et al., 1989) that MAbs CLB-21, CLB-59 and CLB-19.7 reacted with the Cterminal part of p24 (amino acids 180 to 224). Furthermore, these MAbs cross-inhibited each other's reaction with p24 of HIV-1 (Tersmette et al., 1989) . The result with MAb CLB-59 is in accordance with the Pepscan results; however, the results with the other MAbs contrast with the Pepscan results: MAb CLB-21 reacted with nonapeptides 32 to 34, whereas MAb CLB-19.7 reacted with nonapeptides 1, 89 and 90 on the Nterminal part of p24. These conflicting results could be reconciled by assuming that the nonapeptide which reacts with MAb CLB-21 is a fragment of a discontinuous epitope, with a major but in the Pepscan undetected part located on the C-terminal and a minor detected part located on the N-terminal part of p24. The different sites may well be contained within a distance of an average epitope domain with a diameter of approximately 20 A (Amit et al., 1986; Padlan et al., 1989) . As the nonapeptides reactive with MAb CLB-21 are not part of the model, this cannot be checked. A similar reasoning may apply to MAb CLB-19.7. Again, the reactive nonapeptides may be part of a discontinuous epitope of which one part is located on the N and another on the C terminus, whereas on the intact structure both parts may be located next to each other.
The puff region, assumed to be well exposed, should be highly antigenic. In contrast we found only the Cterminal end of the puff region to be antigenic. Interestingly the C-terminal end of the puff which has high turn and coil propensity (Fig. 4b) is predicted to be a B cell epitope by Zvelebil et al. (1988) and Coates et al. (1987) . The low antigenicity of the major part of the puff of p24 may be accounted for by a different secondary structure of this region compared with the corresponding region of VP2 of picornaviruses. In VP2 many coils and turns are present (Acharya et al., 1989) which are predicted to be highly antigenic (Hopp, 1986; Hopp & Woods, 1981) . In contrast only B-strands are predicted for the corresponding p24 region. Thus the proposed p24 puff region may not be a puff but may be more like the further modified structure shown in Fig. 6 . Although this model may be a more realistic interpretation than the initial model of VP2 (Fig. 3) , it should still be regarded as an approximation to the real but unknown structure. This further modified structure incorporates the predicted B-strands and has a shorter loop between strands G and H. In accordance with the immunological data, the amino acids of the puff region in Fig. 3 are less accessible in the further modified structure (Fig. 6 ). Puffs may be the exclusive property of outer proteins which carry essential functions. As p24 is located internally, it may not need a comparable puff at all.
So far, peptides derived from p24 have not been very useful in immunoassays although intact p24 has been very effective Lange et al., 1986) . Our results suggest that this may be caused by the discontinuous character of the major antigenic sites. None of the linear peptides reacted with all sera of HIV-1-infected individuals. However, one or more amino acid sequences on the loops or turns were always involved. If this is the case in general, then the localized reactive amino acid sequences superimposed on a structural model for p24 (Fig. 6) can be used to develop new immunoassays. We speculate that if these complex antigenic sites can be mimicked by peptides, these peptides may be much more effective than peptides based on linear amino acid sequences from the primary structure of p24. Both the 'right' and the 'left' side of p24 (Fig. 6) can be regarded as antigenic sites separated by the//-barrel. The set of reactive peptides on the 'left' may be mimicked by combining the amino acid sequences of turns between strands B and C, strands H and I, strands D and E and strands F and G; the resulting peptide has the amino acid sequence QDLNLGPAATLELQEQIL-RAEQ. The sets of reactive peptides on the 'right' may be mimicked by combining the amino acid sequences of the c~-helix, the insertion between the helix and strand D, the turn between strands G and H and the N-terminal part of the puff; the resulting peptide has the amino acid sequence KETINEEAPIAPGQMQNANPDPVGEI.
Thus our data show that the proposed structure of p24 (Argos, 1989) , slightly refined by us, could be realistic. We speculate that this structure may help the design of more effective peptides to monitor anti-p24 antibodies.
